Purchase Order 36C25624P1264
- Not listed
- This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the delivery of Optune Plus Transducers, which are part of Novocure's Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract is not set aside and is part of a larger $28.85...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company, to provide Optune Plus Transducers. The order has a potential value of $49,748.73 and a completion date of May 31, 2024. This order is part of a larger 5-year Federal Supply Schedule (FSS) contract with the VA VHA valued at up to $28.85 million, which allows the VA to efficiently procure Novocure's Optune tumor...
- This is a purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune Plus Transducers, an FDA-approved cancer therapy device that uses Tumor Treating Fields (TTFields) technology. The contract has a firm fixed price of $49,748.73 and a period of performance through October 31, 2024. The contract does not...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company. The contract has a potential value of $99,173.46 and is to provide Novocure's Optune tumor treating fields (TTFields) therapy devices, transducers, rentals, and support services to VA medical centers and facilities nationwide. Novocure holds a 5-year Federal Supply Schedule (FSS) contract with the VA VHA, valued at...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit organization specializing in cancer therapy with Tumor Treating Fields (TTFields). The contract is to provide Novocure's Optune PLUS transducers, a medical device that delivers therapeutic alternating electric fields to disrupt solid tumor cancer cell division. The contract has a completion date of September 27, 2024 and a...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $33,165.82 contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This order is issued under Novocure's existing 5-year, $28.85 million Federal...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract does not utilize any set-aside designations. Novocure acts...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $21,000.00, is for the delivery of Novocure's Optune Plus Transducers, which are part of the company's Optune system for delivering Tumor Treating Fields (TTFields) therapy to treat solid tumor cancers, including glioblastoma and mesothelioma. This contract is not...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract is part of Novocure's Federal Supply Schedule...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the provision of transducers, with an ultimate completion date of September 17, 2025 and a ceiling value of $49,748.73. Novocure is the prime contractor and will directly provide its Optune medical device system, which utilizes Tumor Treating Fields...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune Plus Transducers, a cancer therapy product utilizing Tumor Treating Fields (TTFields) technology. The contract does not have a set-aside designation and is part of Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA to supply Optune line products and related services. This award enables the VA VHA to procure Novocure's innovative cancer treatment solutions and expand veterans' access to these therapies at VA medical centers nationwide. The contract has an ultimate completion date of August 24, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.7k | 6/27/24 |